Dbx Demineralized Bone Matrix Putty, Dbx Demineralized Bone Matrix Paste
Filler, Bone Void, Osteoinduction (W/O Human Growth Factor). 510(k) K080399, from Musculoskeletal Transplant Foundation (Edison, NJ). Product code MBP, class 2.
As of Nov 19, 2026, K080399 is an FDA 510(k) held by Musculoskeletal Transplant Foundation, substantially equivalent on Oct 10, 2008 after 239 days, with no recalls tied to it in FDA's recall database.
- Review time: 239 days
- Recalls: 0
- Cited as a predicate by: 1 device
DBX® is intended for use as a Demineralized Bone Matrix for voids or gaps that are not intrinsic to the stability of the bony structure. DBX® Putty may be used in the extremities, pelvis, posterolateral spine and cranium. DBX® Mix may be used in the extremities, pelvis and spine. DBX® Paste may be used in the extremities and pelvis.
- Dbx Demineralized Bone Matrix Putty, Bone Matrix Paste and Bone Matrix MixK040262 · Musculoskeletal Transplant Foundation · Mar 17, 2005
- Mtf New Bone Void FillerK110003 · Musculoskeletal Transplant Foundation · Oct 13, 2011
- PliaFX FloK242799 · Lifenet Health · Nov 21, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 14, 2008
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3045
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files